GSK plc (LON:GSK) Given Consensus Rating of "Moderate Buy" by Analysts

Shares of GSK plc (LON:GSK - Get Free Report) have earned a consensus recommendation of "Moderate Buy" from the seven ratings firms that are presently covering the stock, Marketbeat.com reports. One analyst has rated the stock with a sell rating, one has assigned a hold rating and five have given a buy rating to the company. The average 12-month price objective among analysts that have issued ratings on the stock in the last year is GBX 1,805.83 ($22.73).

A number of equities research analysts have weighed in on the stock. JPMorgan Chase & Co. reissued an "underweight" rating on shares of GSK in a report on Tuesday, January 7th. Berenberg Bank reduced their price objective on shares of GSK from GBX 1,820 ($22.91) to GBX 1,600 ($20.14) and set a "buy" rating for the company in a research note on Friday, November 29th.

Insider Activity

In related news, insider Emma Walmsley sold 120,653 shares of the stock in a transaction that occurred on Monday, February 10th. The stock was sold at an average price of GBX 1,453 ($18.29), for a total value of £1,753,088.09 ($2,206,530.01). Also, insider Jonathan Symonds acquired 1,500 shares of the company's stock in a transaction that occurred on Friday, December 20th. The stock was purchased at an average price of GBX 1,315 ($16.55) per share, for a total transaction of £19,725 ($24,826.94). 1.61% of the stock is owned by corporate insiders.

GSK Price Performance

GSK traded down GBX 9.50 ($0.12) on Friday, reaching GBX 1,435 ($18.06). The company had a trading volume of 5,979,453 shares, compared to its average volume of 26,154,219. The company has a fifty day moving average of GBX 1,367.43 and a 200-day moving average of GBX 1,454.89. The company has a market capitalization of £58.23 billion, a P/E ratio of 23.18, a PEG ratio of 1.24 and a beta of 0.31. The company has a current ratio of 0.81, a quick ratio of 0.73 and a debt-to-equity ratio of 114.64. GSK has a one year low of GBX 1,282.50 ($16.14) and a one year high of GBX 1,823.50 ($22.95).

GSK (LON:GSK - Get Free Report) last issued its quarterly earnings results on Wednesday, February 5th. The company reported GBX 23.20 ($0.29) earnings per share for the quarter. GSK had a net margin of 8.02% and a return on equity of 18.08%. As a group, equities research analysts anticipate that GSK will post 175.980975 earnings per share for the current year.

About GSK

GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through two segments, Commercial Operations and Total R&D.